The study team retrospectively included adult ICU patients aged 18 years or older with a diagnosis of acute kidney injury and labeled each patient according to delirium events occurring during the ICU stay. The cohort was randomly split 70:30 into a training set and a validation set. The authors reported that training-set procedures informed model construction while a held-out validation set provided an independent assessment of performance. The paper did not detail the specific diagnostic criteria or timing used to assign the delirium label; the source did not report those operational specifics.
In the training set, investigators applied the Boruta algorithm to select confirmed predictors. Those Boruta-confirmed variables were fed into nine supervised machine learning classifiers. The paper identified the classifier family but did not list all nine models by name in the abstract; therefore, the exact roster beyond the ultimately top-performing model is not reported in the source. Training proceeded on the selected features, with the aim of producing a parsimonious predictive model for ICU delirium among patients with AKI.
Model performance was assessed in the validation cohort using area under the receiver operating characteristic curve (ROC AUC), calibration plots, and decision curve analysis. Among the validation cohort, the boosting algorithm CatBoost showed the best discrimination, with an AUC of 0.742 (95% confidence interval = 0.676–0.809). The authors also evaluated calibration visually with calibration plots and examined potential clinical utility via decision curve analysis; the abstract reports those assessments were performed but does not provide calibration slope values, net benefit numbers, or decision-curve thresholds. Data indicated moderate discrimination rather than excellent or near-perfect performance.
To interpret model outputs, the study team calculated SHapley Additive exPlanations (SHAP) values for the final model. SHAP analysis identified five variables as the most influential predictors of delirium in this AKI cohort: diabetes, pneumonia, serum chloride, red blood cell count, and prothrombin time. The authors reported these features as the top contributors to model prediction, but the abstract does not provide the directionality or the magnitude of effect for each variable beyond their ranking. Clinicians reading the report should note that SHAP highlights variable importance within the model context, not causal relationships.
The study team proposed that a CatBoost model built on Boruta-confirmed clinical variables could help clinicians recognize patients at higher risk of delirium during ICU care. Variables such as comorbid diabetes and concurrent pneumonia are familiar clinical risk markers; lab values—chloride, red blood cell count, and prothrombin time—appeared as influential physiological signals in the model. The authors suggested these predictors may aid in prioritizing preventive measures for high-risk patients. The source did not report how the model would be integrated into clinical workflows, whether it would run in real time, or whether thresholds for action were proposed; those implementation details were not included in the abstract.
The investigators described a retrospective design, which limits causal inference and can introduce selection and information biases inherent to chart-based analyses. The abstract states that external validation is needed before wider clinical use. The source did not report calibration statistics numerically, nor did it provide details about missing data handling, the full list of candidate predictors considered prior to Boruta selection, or the exact delirium-detection method used in the ICU. These omissions constrain assessment of generalizability and replication. Future work should externally validate the CatBoost model, disclose the full model specification, and specify delirium labeling criteria to support implementation in other ICU settings.